Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Regeneron Pharmaceuticals

Market Cap: US$57.9b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Daiichi Sankyo Company

Market Cap: JP¥6.6t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Summit Therapeutics

Market Cap: US$18.3b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

ALTEOGEN

Market Cap: ₩18.4t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Genmab

Market Cap: DKK 82.1b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

BioMarin Pharmaceutical

Market Cap: US$11.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Roivant Sciences

Market Cap: US$7.9b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Revolution Medicines

Market Cap: US$7.8b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Corcept Therapeutics

Market Cap: US$7.6b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

BridgeBio Pharma

Market Cap: US$6.6b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Chongqing Zhifei Biological Products

Market Cap: CN¥46.1b

Chongqing Zhifei Biological Products Co., Ltd.

Jazz Pharmaceuticals

Market Cap: US$6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Grifols

Market Cap: €5.1b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Axsome Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Ionis Pharmaceuticals

Market Cap: US$5.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Beijing Tiantan Biological Products

Market Cap: CN¥37.7b

Beijing Tiantan Biological Products Co., Ltd.

Nuvalent

Market Cap: US$5.1b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

SK Biopharmaceuticals

Market Cap: ₩7.1t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

Zealand Pharma

Market Cap: DKK 30.3b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

H. Lundbeck

Market Cap: DKK 29.2b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Krystal Biotech

Market Cap: US$4.0b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Cytokinetics

Market Cap: US$3.9b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Sarepta Therapeutics

Market Cap: US$3.6b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Avidity Biosciences

Market Cap: US$3.4b

A biopharmaceutical company, engages in the delivery of RNA therapeutics.

Ultragenyx Pharmaceutical

Market Cap: US$3.4b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Dottikon ES Holding

Market Cap: CHF 2.8b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide.

Akero Therapeutics

Market Cap: US$3.4b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Zai Lab

Market Cap: US$3.2b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Arcellx

Market Cap: US$3.2b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Viking Therapeutics

Market Cap: US$3.1b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

CRISPR Therapeutics

Market Cap: US$3.1b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Crinetics Pharmaceuticals

Market Cap: US$3.1b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.